Background: Secondary hyperparathyroidism commonly arises in individuals with end-stage kidney disease, especially those who undergo maintenance hemodialysis (MHD). This study investigated strategies and effectiveness of nursing interventions in MHD patients with secondary hyperparathyroidism complications.
Methodology: This study is a retrospective analysis conducted at the General Hospital of Northern Theater Command. From June 2021 to June 2023, 212 patients undergoing MHD were selected for the study. They were divided into 2 groups based on their parathyroid hormone levels: a hyperthyroidism group and a standard group. Within the hyperthyroidism group, participants were randomly assigned to either the control group (CG), which received routine nursing, or the observation group (OG), which received targeted nursing. The study assessed several primary outcome measures, including patient risk factors, nursing satisfaction, psychological status, quality of life, treatment compliance, and nutritional indexes.
Results: Significant disparities existed in the age, diabetes presence, pulse pressure, duration of dialysis, and levels of creatinine, C-reactive protein, phosphorus, triglyceride, albumin, calcium, and phosphorus product between the hyperthyroidism and the standard group. The duration of dialysis, presence of diabetes, C-reactive protein, and blood phosphorus were identified as independent risk factors for maintaining secondary hyperparathyroidism in patients undergoing hemodialysis. Overall satisfaction with nursing care and compliance with treatment were significantly higher in the observation group compared to the CG. Following nursing care, the scores on the Self-rating Anxiety Scale and the Self-rating Depression Scale were substantially lower in the OG compared to the CG. After nursing care, the biochemical indicators were lower, the nutritional indicators were higher, and the quality of life scores were significantly improved in the OG compared to the CG.
Conclusion: Targeted nursing interventions in the care of hemodialysis patients with hyperparathyroidism enhanced serological markers, alleviated negative emotions, and improved patients' quality of life and nutritional status.